Cargando…

Characteristics of ADHD Symptom Response/Remission in a Clinical Trial of Methylphenidate Extended Release

Clinical trials in attention-deficit/hyperactivity disorder (ADHD) have typically measured outcome using clinician ratings on the Attention-Deficit/Hyperactivity Disorder Rating Scale, Fourth Edition (ADHD-RS-IV) and the Clinical Global Impression-Improvement (CGI-I) scale. Remission has been define...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weiss, Margaret, Childress, Ann, Nordbrock, Earl, Adjei, Akwete L., Kupper, Robert J., Mattingly, Greg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517933/ https://www.ncbi.nlm.nih.gov/pubmed/30959790 http://dx.doi.org/10.3390/jcm8040461

Ejemplares similares

Effect of Aptensio XR (Methylphenidate HCl Extended-Release) Capsules on Sleep in Children with Attention-Deficit/Hyperactivity Disorder
por: Owens, Judith, et al.
Publicado: (2016)

Relationship Between Symptomatic and Functional Improvement and Remission in a Treatment Response to Stimulant Trial
por: Weiss, Margaret, et al.
Publicado: (2018)

Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study
por: Wigal, Sharon B., et al.
Publicado: (2015)

Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR) in Preschool Children with Attention-Deficit/Hyperactivity Disorder
por: Childress, Ann C., et al.
Publicado: (2020)

Efficacy and Safety of PRC-063, Extended-Release Multilayer Methylphenidate in Adults with ADHD Including 6-Month Open-Label Extension
por: Weiss, Margaret D., et al.
Publicado: (2020)

Population pharmacokinetics of methylphenidate hydrochloride extended-release multiple-layer beads in pediatric subjects with attention deficit hyperactivity disorder
por: Teuscher, Nathan S, et al.
Publicado: (2015)

A Pharmacokinetic Study of Methylphenidate Hydrochloride Multilayer Extended-Release Capsules (Aptensio XR(®)) in Preschool-Aged Children with Attention-Deficit/Hyperactivity Disorder
por: Adjei, Akwete L., et al.
Publicado: (2020)

Analysis of Daily Sleep Diary Measures From Multilayer Extended-Release Methylphenidate (PRC-063) Studies in Children and Adults With ADHD
por: Cataldo, Marc, et al.
Publicado: (2022)

Optimization of Methylphenidate Extended-Release Chewable Tablet Dose in Children with ADHD: Open-Label Dose Optimization in a Laboratory Classroom Study
por: Wigal, Sharon B., et al.
Publicado: (2018)

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Adult Laboratory Classroom Study of the Efficacy and Safety of PRC-063 (Extended-Release Methylphenidate) for the Treatment of ADHD
por: Childress, Ann, et al.
Publicado: (2021)

The Weighed Core Symptom Scale and Prediction of ADHD in Adults – Objective Measures of Remission and Response to Treatment with Methylphenidate
por: Edebol, Hanna, et al.
Publicado: (2013)

Pharmacokinetics of Coadministration of Guanfacine Extended Release and Methylphenidate Extended Release
por: Roesch, Benno, et al.
Publicado: (2013)

Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder
por: Wigal, Sharon B., et al.
Publicado: (2017)

An observational study of once-daily modified-release methylphenidate in ADHD: effectiveness on symptoms and impairment, and safety
por: Döpfner, Manfred, et al.
Publicado: (2011)

Randomized Controlled Crossover Trials of the Pharmacokinetics of PRC-063, a Novel Multilayer Extended-Release Formulation of Methylphenidate, in Healthy Adults
por: Katzman, Martin A., et al.
Publicado: (2020)

ADHD, Methylphenidate, and Childhood Epilepsy
por: Sharma, Rahul, et al.
Publicado: (2016)

An observational study of once-daily modified-release methylphenidate in ADHD: the effect of previous treatment on ADHD symptoms, other externalising symptoms and quality-of-life outcomes
por: Döpfner, Manfred, et al.
Publicado: (2011)

Methylphenidate Efficacy: Immediate versus Extended Release at Short Term in Mexican Children with ADHD Assessed by Conners Scale and EEG
por: Durand-Rivera, Alfredo, et al.
Publicado: (2015)

Single-Dose Pharmacokinetics of HLD200, a Delayed-Release and Extended-Release Methylphenidate Formulation, in Healthy Adults and in Adolescents and Children with Attention-Deficit/Hyperactivity Disorder
por: Childress, Ann, et al.
Publicado: (2018)

Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder
por: Newcorn, Jeffrey H., et al.
Publicado: (2017)

Clinically Meaningful Improvements in Early Morning and Late Afternoon/Evening Functional Impairment in Children with ADHD Treated with Delayed-Release and Extended-Release Methylphenidate
por: Wilens, Timothy E., et al.
Publicado: (2021)

Methylphenidate-Induced Psychotic Symptoms in 65-Year-Old Female with ADHD
por: Ghadrdan, Elliyeh, et al.
Publicado: (2018)

Multiscale assessment of treatment efficacy in adults with ADHD: A randomized placebo-controlled, multi-centre study with extended-release methylphenidate
por: Retz, Wolfgang, et al.
Publicado: (2012)

The Risk of Methylphenidate Pharmacotherapy for Adults with ADHD
por: Bieś, Rafał, et al.
Publicado: (2023)

A Single-Dose, Single-Period Pharmacokinetic Assessment of an Extended-Release Orally Disintegrating Tablet of Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
por: Childress, Ann, et al.
Publicado: (2016)

Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting
por: Childress, Ann C., et al.
Publicado: (2017)

Effect of Methylphenidate on Sleep Parameters in Children with ADHD
por: Lee, Sang Heon, et al.
Publicado: (2012)

Postural Instability in Children with ADHD Is Improved by Methylphenidate
por: Bucci, Maria P., et al.
Publicado: (2016)

The Effect of Methylphenidate on Neurological Soft Signs in ADHD
por: Hrtanek, Igor, et al.
Publicado: (2015)

Efficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom Study
por: Childress, Ann C., et al.
Publicado: (2020)

Cost-Effectiveness of Extended-Release Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Sub-Optimally Treated with Immediate Release Methylphenidate
por: van der Schans, Jurjen, et al.
Publicado: (2015)

Effect of a Multi-Layer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adults with ADHD: A Randomized, Double-Blind, Forced-Dose, Placebo-Controlled Trial Followed by a 6-month Open-Label Extension
por: Weiss, Margaret Danielle, et al.
Publicado: (2021)

Dopaminergic and Noradrenergic Contributions to Functionality in ADHD: The Role of Methylphenidate
por: Engert, Veronika, et al.
Publicado: (2008)

Occurrence of psychotic symptoms during treatment of ADHD with methylphenidate: Clinical significance and the need for further research
por: Reiersen, Angela M.
Publicado: (2018)

Editorial: Observational studies in ADHD: the effects of switching to modified-release methylphenidate preparations on clinical outcomes and adherence
por: Rothenberger, Aribert, et al.
Publicado: (2011)

An observational study of once-daily modified-release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherence
por: Rothenberger, Aribert, et al.
Publicado: (2011)

Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Methylphenidate in Healthy Adults
por: Faison, Shamia L., et al.
Publicado: (2020)

The influence of methylphenidate on the power spectrum of ADHD children – an MEG study
por: Wienbruch, Christian, et al.
Publicado: (2005)

Methylphenidate significantly improves declarative memory functioning of adults with ADHD
por: Verster, Joris C., et al.
Publicado: (2010)

Comorbidities in ADHD children treated with methylphenidate: a database study
por: Kraut, Angela A, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gpt8ba384fj69n1dg7tar48ge1